期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Ethical review of off-label drugs during the COVID-19 pandemic
1
作者 Qiu-Yu Li Ye Lv +4 位作者 Zhuo-Yu An Ni-Ni Dai Xue Hong Yu Zhang Li-Jun Liang 《World Journal of Clinical Cases》 SCIE 2022年第17期5541-5550,共10页
High-quality scientific research is very important in attempting to effectively control the coronavirus disease 2019(COVID-19)pandemic and ensure people’s health and safety.Chloroquine(CQ)and hydroxychloroquine(HCQ)h... High-quality scientific research is very important in attempting to effectively control the coronavirus disease 2019(COVID-19)pandemic and ensure people’s health and safety.Chloroquine(CQ)and hydroxychloroquine(HCQ)have received much attention.This article comprehensively investigates the ethical review of off-label CQ and HCQ research during the COVID-19 pandemic with regard to strictly abiding by review standards,improving review efficiency,ensuring the rights and interests of subjects and that ethics committees conduct independent reviews,and achieving full ethics supervision of research conducted during an emergency.Research must be both rigorous and prudent to ensure the best outcome,with the maximization of benefits as the core principle.Standardization of the application,implementation and ethical review processes are needed to prevent unnecessary risk. 展开更多
关键词 COVID-19 OFF-LABEL CHLOROQUINE HYDROXYCHLOROQUINE
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部